Please login to the form below

Not currently logged in
Email:
Password:

Ovarian canncer

This page shows the latest Ovarian canncer news and features for those working in and with pharma, biotech and healthcare.

Another NICE no for AZ’s new ovarian cancer drug

Another NICE no for AZ’s new ovarian cancer drug

The Institute is minded, in preliminary draft guidance, to reject Lynparza (olaparib) for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube and peritoneal cancer. ... People who have BRCA 1 or 2 gene mutations have an increased

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...